ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma

Hailong Sheng(Nanfang Hospital), Chuanhui Cao(Ganzhou People's Hospital), Yan Huang(National Center of Biomedical Analysis), Yazhi Xiao(Nanfang Hospital), Ze-Qin Guo(Nanfang Hospital), Jian Wang(Shandong Provincial Hospital), Hui Wang, Wanjun Zhang(Baoding People's Hospital), Jingyuan Sun(Nanfang Hospital), Peitao Zhou(Nanfang Hospital), Mengying Shen(Nanfang Hospital), Wencong Dai(Nanfang Hospital), Zhenru Zhu(Nanfang Hospital)
Journal for ImmunoTherapy of Cancer
May 1, 2020
Cited by 225


Related Papers